Molina Healthcare — Feb 5, 2025 release
Fiscal 2024 fourth-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0001179929-25-000020
Showing in the filing
Premium revenue
“approximately $42 billion”
Period
FY2025
Measure
GAAP-tied
Source
Prose
All guidance in this release · 28
Premium revenue for FY2025
“approximately $42 billion”
Adjusted earnings for FY2025
“at least $24.50 per diluted share”
Implementation Costs for Duals Contract Wins for FY2025
“approximately $1.00 per diluted share”
Adjusted EPS Growth (yield, excluding implem… for FY2025
“approximately 13% growth over 2024”
New Store Embedded Earnings for FY2026
“$7.75 per diluted share”
GAAP earnings per share for FY2025
“at least $22.50 per share”
GAAP EPS for FY2025
“at least $22.50 per share”
Adjusted EPS Growth (as reported) for FY2025
“8% growth over the full year 2024”
Premium Revenue for FY2025
“$42.0B”
Total Revenue for FY2025
“$44.0B”
GAAP Net Income for FY2025
“$1,251M”
Adjusted Net Income for FY2025
“$1,362M”
GAAP EPS - Diluted for FY2025
“>$22.50”
Adjusted EPS - Diluted for FY2025
“>$24.50”
Diluted weighted average shares for FY2025
“55.6M”
Year End Total Membership for FY2025
“5.9M”
Medicaid Membership for FY2025
“5.0M”
Year End Total Membership - Medicaid for FY2025
“5.0M”
Medicare Membership for FY2025
“250K”
Year End Total Membership - Medicare for FY2025
“250K”
Marketplace Membership for FY2025
“580K”
Year End Total Membership - Marketplace for FY2025
“580K”
MCR for FY2025
“88.7%”
GAAP G&A Ratio for FY2025
“7.2%”
Adjusted G&A Ratio for FY2025
“7.0%”
Effective Tax Rate for FY2025
“25.3%”
Adjusted After-tax Margin for FY2025
“3.1%”
Estimated Non-Recurring Costs for Recently A…
“approximately $20 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
• GAAP net income was $20.42 per diluted share for the full year 2024, an increase of 9% year over year. • Adjusted net income was $22.65 per diluted share for the full year 2024, an increase of 8% year over year. • The Company issued its full year 2025 earnings guidance with expected premium revenue of approximately $42 billion and adjusted earnings of at least $24.50 per diluted share, which includes approximately $1.00 per diluted share of implementation costs for recent -MORE- Molina Healthcare, Inc. Reports Fourth Quarter and Year-End 2024 Financial Results Page 2 February 5, 2025 Medicaid and Medicare Duals contract wins scheduled to commence in 2026 and yields approximately 13% growth over 2024. • New store embedded earnings is now at $7.75 per diluted share and reflects recent Medicaid and Medicare Duals contract wins. “I am very pleased our 2024 revenue growth exceeded our long-term targets and we produced consolidated pre-tax margins within our long-term target range,” said Joseph Zubretsky, President and Chief Executive Officer. “Our earnings growth profile is solid heading into 2025, and we continue to execute on the long-term growth opportunities within all of our businesses. We remain confident in our ability to achieve our long-term financial targets.” Premium Revenue Premium revenue was approximately $38.6 billion for the full year 2024, an increase of 19% year over year. The higher premium revenue reflects new contract wins, acquisitions, and growth in our current footprint, partially off
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.